A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulators.

Front Genet · 2022 · PMC9666757 · PMID 36406115

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

These results suggest that detecting CD79B expression may be significant for differentiating cervical cancer types and for predicting patient outcomes and prognosis, but not for indicating the extent of metastasis, progression, or infiltration.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.